Prostate cancer: incorporating genomic biomarkers in prostate cancer decisions
Read an article from Dr. Crawford from Clinical Perspective to learn which genomic biomarkers are most useful in prostate cancer. Click here to learn more
PROFESSOR OF SURGERY, UROLOGY AND RADIATION ONCOLOGY
HEAD, UROLOGIC ONCOLOGY
UNIVERSITY OF COLORADO
ANSCHUTZ MEDICAL CAMPUS